The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose escalation and dose expansion study of the anti-programmed cell death-1 (PD-1) antibody AK105.
 
Dusan Kotasek
No Relationships to Disclose
 
Jermaine Coward
No Relationships to Disclose
 
Paul L. de Souza
Honoraria - Janssen
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Janssen; Pfizer
Research Funding - Multiple pharma companies
Expert Testimony - Janssen
 
Craig Underhill
No Relationships to Disclose
 
Xiaoping Jin
Employment - United Health Group (I)
Stock and Other Ownership Interests - United Health Group (I)
 
Baiyong Li
No Relationships to Disclose
 
Yu Xia
No Relationships to Disclose
 
Amy Prawira
Research Funding - Akeso Biopharma (Inst); Arcus Biosciences (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CBT Pharmaceuticals (Inst); CStone Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)